Study of a Severe Acute Respiratory Syndrome CoV-2 (SARS-CoV-2) Virus-like Particle (VLP) Vaccine in Healthy Adults
Clinical trial NCT04818281 · COMPLETED
Trial details
- NCT number
- NCT04818281
- Sponsor
- Ihsan GURSEL, PhD, Prof.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-27
- Primary completion
- 2021-12-29
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.